In CT26 and HNM007 mice, LD‐EM therapy demonstrated superior tumor inhibition compared with commonly used chemotherapy alone (TGI of 59.9% vs. 36.6% for CT26; 77.3% vs. 37.4% for HNM007, respectively; p < 0.05). This evidence concerns the gene DDX53 and neoplasm.